Nova Biochem key facts
as of Oct 2026- Developer of an engineering technology platform designed to create alternatives to traditional petrochemicals.
- Nova Biochem is valued at approximately $11.2M as of Oct 2026 (last reported valuation).
- It has raised $3.7M; the latest was Seed Round ($3.1M) in Oct 2025.
- Notable investors include Forest Valley Institute, Archipelago Ventures (London), Circular Bio-based Europe Joint Undertaking, Circular Plastics Accelerator, Circulate Capital — 7 tracked in total.
- Status: Privately Held (backing).
Nova Biochem's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·Watch Nova Biochem: the Monday email on marks, rounds and moves
Nova Biochem funding rounds
No funding rounds for Nova Biochem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Nova Biochem valuation
Nova Biochem's last reported valuation was $11.2 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Nova Biochem investors
7 investors are on record for Nova Biochem, including Forest Valley Institute, Archipelago Ventures (London), Circular Bio-based Europe Joint Undertaking and Circular Plastics Accelerator.
About Nova Biochem
Developer of an engineering technology platform designed to create alternatives to traditional petrochemicals. The company's platform uses a water-based clean process to convert waste streams from pulping and agriculture, specifically lignin, into bio-based chemicals and building blocks, enabling businesses to utilize more sustainable materials, potentially reducing reliance on fossil fuels and creating a cleaner future.
- Sector
- Materials and Resources
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 4
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.